Abstract:There have been over 17 million COVID-19 infections worldwide up to July 31, 2020, but the exact transmission route remains a subject for debate. Virus load in different-sized respiratory droplets is the key to address the above question. Investigation on the droplet deposition characteristics during exhalation inside the respiratory tract will facilitate the understanding of their origin and importance in transmitting the respiratory infection. Based on a realistic respiratory model, this study utilized the computational fluid dynamic (CFD) simulation to investigate the deposition of droplets originating from infection sites like pharynx, larynx and trachea under three flow conditions, namely 30 L/min (representing the normal breathing condition), 60 L/min (speaking) and 180 L/min (coughing). The SST k-omega turbulence model integrated in ANSYS Fluent software was utilized to obtain the flow field inside the respiratory tract by solving the continuity and momentum equations, and the Lagrangian approach was used to calculate droplet motion and deposition with the discrete random walk model to account for the turbulence fluctuation effect. Evaporation of droplets was not considered inside the saturated respiratory tract. Droplet diameter, flow rate of the exhaling air, and complexity of the respiratory tract geometry are the most important factors in determining the deposition pattern of respiratory droplets. It is revealed that the largest droplet that originates from the joint of pharynx and larynx and is able to escape out of the respiratory tract is about 20 mu m (30 L/min) or 10 mu m (60-180 L/min) in diameter; the so-called cut-off sizes for vocal cord and trachea originated droplets are 7 mu m (30 L/min), 5 mu m (60 L/min) or 3 mu m (180 L/min). Larynx and joint of larynx and pharynx are the most important deposition sites due to their complexity in geometry and the existence of the laryngeal jet, whose velocity is up to 102 m/s during coughing and 32 m/s during speaking; the nasal cavity is also effective in trapping relatively small droplets as the airflow has a sudden change in direction before entering the oral cavity. Under the investigated speaking scenario (60 L/min), the escape rate of 1 mu m droplets is around 50%, and the maximum escape rates of 5 and 10 mu m droplets are respectively 13.1% and 1.3% (originating from the joint of pharynx and larynx). Although large droplets up to several hundred micrometers can be produced inside the oral cavity due to the atomization mechanism, they seldom carry pathogen. Thus, for COVID-19 patents in the early stage of infection who show upper respiratory symptoms, the cut-off size of virus-laden droplets released into the environment is about 20 mu m; with the shifting of infection to the lower respiratory tract in the later stage, the cut-off size decreases to 7 mu m. Respiratory droplets evaporate immediately after escaping into the indoor environments and shrink to about one third of their initial size, so airborne route is speculated to be important in the transmission of COVID-19. Further investigations considering realistic flow conditions together with droplet sampling experiments on human volunteers are necessary to confirm these cut-off sizes.

High amounts of SARS-CoV-2 in aerosols exhaled by patients with Omicron variant infection

Coronavirus Disease 2019 Patients in Earlier Stages Exhaled Millions of Severe Acute Respiratory Syndrome Coronavirus 2 Per Hour

COVID-19 patients in earlier stages exhaled millions of SARS-CoV-2 per hour.

Numerical Investigation on the Origin of Virus-Laden Droplets in the Respiratory Tract

Exhaled breath is a significant source of SARS-CoV-2 emission

Higher SARS‐CoV‐2 shedding in exhaled aerosol probably contributed to the enhanced transmissibility of Omicron BA.5 subvariant

Similar aerosol emission rates and viral loads in upper respiratory tracts for COVID-19 patients with Delta and Omicron variant infection

Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals

Severe acute respiratory syndrome coronavirus 2 can be detected in exhaled aerosol sampled during a few minutes of breathing or coughing

Detection of SARS-CoV-2 in Exhaled Breath from COVID-19 Patients Ready for Hospital Discharge

Determinants of SARS-CoV-2 Receptor Gene Expression in Upper and Lower Airways

Multi-route Transmission Potential of SARS-CoV-2 in Healthcare Facilities.

Delayed Clearance of Viral RNA in Sputum for Severity COVID-19 Patients with Initial High Viral Load

Temporal and Spatial Distribution of SARS-CoV-2 Aerosols in a Large-Scale Fangcang Shelter Hospital in Shanghai, China

SARS-CoV-2 Aerosol Exhaled by Experimentally Infected Cynomolgus Monkeys

Aerodynamic Characteristics and RNA Concentration of SARS-CoV-2 Aerosol in Wuhan Hospitals during COVID-19 Outbreak

Detecting SARS-CoV-2 in the Breath of COVID-19 Patients

Frequency, kinetics and determinants of viable SARS-CoV-2 in bioaerosols from ambulatory COVID-19 patients infected with the Beta, Delta or Omicron variants

Duration of viable virus shedding and PCR positivity of the SARS-CoV-2 Omicron variant in upper respiratory tract: a systematic review and meta-analysis

Research progress of severe acute respiratory syndrome coronavirus 2 on aerosol collection and detection

Duration of Viable Virus Shedding and Polymerase Chain Reaction Positivity of the SARS-CoV-2 Omicron Variant in the Upper Respiratory Tract: a Systematic Review and Meta-Analysis